E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation

被引:51
作者
Asp, Patrik [1 ]
Acosta-Alvear, Diego [1 ]
Tsikitis, Mary [1 ]
van Oevelen, Chris [1 ]
Dynlacht, Brian David [1 ]
机构
[1] NYU, Inst Canc, Sch Med, New York, NY 10016 USA
关键词
E2F; E2f3b; cell cycle; ChIP-on-chip; myogenic differentiation; CELL-CYCLE PROGRESSION; TUMOR-SUPPRESSOR; TRANSCRIPTION; PROTEIN; MOUSE; RB; EXPRESSION; IDENTIFICATION; REPLICATION; APOPTOSIS;
D O I
10.1101/gad.1727309
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Current models posit that E2F transcription factors can be divided into members that either activate or repress transcription, in part through collaboration with the retinoblastoma (pRb) tumor suppressor family. The E2f3 locus encodes E2f3a and E2f3b proteins, and available data suggest that they regulate cell cycle-dependent gene expression through opposing transcriptional activating and repressing activities in growing and quiescent cells, respectively. However, the role, if any, of E2F proteins, and in particular E2f3, in myogenic differentiation is not well understood. Here, we dissect the contributions of E2f3 isoforms and other activating and repressing E2Fs to cell cycle exit and differentiation by performing genome-wide identification of isoform-specific targets. We show that E2f3a and E2f3b target genes are involved in cell growth, lipid metabolism, and differentiation in an isoform-specific manner. Remarkably, using gene silencing, we show that E2f3b, but not E2f3a or other E2F family members, is required for myogenic differentiation, and that this requirement for E2f3b does not depend on pRb. Our functional studies indicate that E2f3b specifically attenuates expression of genes required to promote differentiation. These data suggest how diverse E2F isoforms encoded by a single locus can play opposing roles in cell cycle exit and differentiation.
引用
收藏
页码:37 / 53
页数:17
相关论文
共 40 条
[1]   XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks [J].
Acosta-Alvear, Diego ;
Zhou, Yiming ;
Blais, Alexandre ;
Tsikitis, Mary ;
Lents, Nathan H. ;
Arias, Carolina ;
Lennon, Christen J. ;
Kluger, Yuval ;
Dynlacht, Brian David .
MOLECULAR CELL, 2007, 27 (01) :53-66
[2]   Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics [J].
Aslanian, A ;
Iaquinta, PJ ;
Verona, R ;
Lees, JA .
GENES & DEVELOPMENT, 2004, 18 (12) :1413-1422
[3]   An initial blueprint for myogenic differentiation [J].
Blais, A ;
Tsikitis, M ;
Acosta-Alvear, D ;
Sharan, R ;
Kluger, Y ;
Dynlacht, BD .
GENES & DEVELOPMENT, 2005, 19 (05) :553-569
[4]   E2F-associated chromatin modifiers and cell cycle control [J].
Blais, Alexandre ;
Dynlacht, Brian D. .
CURRENT OPINION IN CELL BIOLOGY, 2007, 19 (06) :658-662
[5]   Retinoblastoma tumor suppressor protein-dependent methylation of histone H3 lysine 27 is associated with irreversible cell cycle exit [J].
Blais, Alexandre ;
van Oevelen, Chris J. C. ;
Margueron, Raphael ;
Acosta-Alvear, Diego ;
Dynlacht, Brian David .
JOURNAL OF CELL BIOLOGY, 2007, 179 (07) :1399-1412
[6]   Emerging roles for E2F: Beyond the G1/S transition and DNA replication [J].
Cam, H ;
Dynlacht, BD .
CANCER CELL, 2003, 3 (04) :311-316
[7]   The WSTF-SNF2h chromatin remodeling complex interacts with several nuclear proteins in transcription [J].
Cavellan, Erica ;
Asp, Patrik ;
Percipalle, Piergiorgio ;
Ostlund Farrants, Ann-Kristin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (24) :16264-16271
[8]   Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a [J].
Chen, Danian ;
Opavsky, Rene ;
Pacal, Marek ;
Tanimoto, Naoyuki ;
Wenzel, Pamela ;
Seeliger, Mathias W. ;
Leone, Gustavo ;
Bremner, Rod .
PLOS BIOLOGY, 2007, 5 (07) :1504-1519
[9]   Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo [J].
Cloud, JE ;
Rogers, C ;
Reza, TL ;
Ziebold, U ;
Stone, JR ;
Picard, MH ;
Caron, AM ;
Bronson, RT ;
Lees, JA .
MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (08) :2663-2672
[10]   E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity [J].
Danielian, P. S. ;
Friesenhahn, L. B. ;
Faust, A. M. ;
West, J. C. ;
Caron, A. M. ;
Bronson, R. T. ;
Lees, J. A. .
ONCOGENE, 2008, 27 (51) :6561-6570